Home/ Supplements/ Niacin/ Ultimate Pre-Workout Blue Razz

Ultimate Pre-Workout Blue Razz

product on market Powder ABE All Black Everything Safety: 98/100
98/100

This product looks safe

  • Niacin: 40mg is 1.1× the Tolerable Upper Intake Level (35mg)
  • 53% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Citrulline malate is supported by strong evidence for improving exercise performance and endurance. B-vitamins and choline contribute to energy metabolism and cognitive function, though their impact on athletic output is more limited. The profile maintains a high safety score with no significant concerns noted.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 40mg is 1.1× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for Ultimate Pre-Workout Blue Razz
Open Full PDF View on NIH DSLD →
Details

Label Data

13 Gram(s)
Serving Size
30
Servings
Other Combinations
Product Type
53%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

40 mg (250% DV)
Exceeds UL by 1.1× (UL: 35 mg) 196 studies (A:5, B:63)
100 mcg (4167% DV)
41.7× RDA — above typical dose 139 studies (A:1, B:44)
Sodium
204 mg (9% DV)
82.5 mg (15% DV)
Within RDA (0.1× RDA) 38 studies (A:1, B:7)
Market median: 2000.0mg (275 products)
3000 mg
Market median: 1500.0mg (104 products) 21 studies (A:0, B:2)
Market median: 180.0mg (239 products) 49 studies (A:1, B:19)
250 mg
Within RDA (0.5× RDA) 38 studies (A:1, B:7)
200 mg
Market median: 500.0mg (223 products) 24 studies (A:0, B:1)
200 mg
Market median: 200.0mg (358 products) 9 studies (A:0, B:2)
Zynamite
140 mg
Dynamine
100 mg
Senactiv
50 mg
AstraGin
50 mg
90 mcg
Market median: 0.15mg (41 products)

Other Ingredients

Natural Flavors Citric Acid Sodium Bicarbonate Silicon Dioxide Calcium Silicate Spirulina Sucralose
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Formulation Notes

Blue Razz natural flavor

Informed Choice We test - You trust Regularly tested for banned substances

Additional Information

Informed Choice We test - You trust Regularly tested for banned substances

Metadata

Product Details

DSLD Entry Date2024-11-22
Product TypeOther Combinations
FormPowder
DSLD ID305214
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.